Foghorn Therapeutics Inc.
Ticker: 1822462
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 16.07+391.4% | 3.27-59.9% | 8.15+7.8% | 7.56+27.1% | 5.95-23.8% | 7.81+13.4% | 6.89+36.4% | 5.05 |
| Total Income | 16.07+391.4% | 3.27-59.9% | 8.15+7.8% | 7.56+27.1% | 5.95-23.8% | 7.81+13.4% | 6.89+36.4% | 5.05 |
| EXPENSES | ||||||||
| Expenditure | 24.88+0.2% | 24.84-6.8% | 26.65-7.0% | 28.65-0.8% | 28.87-8.8% | 31.66-5.5% | 33.52+0.8% | 33.24 |
| Tax | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | — | — | — | — | — | -19.12+16.8% | -22.98+8.2% | -25.02 |
| Net Profit | -7.19+63.8% | -19.88-25.4% | -15.85+11.6% | -17.94+4.7% | -18.83+1.5% | -19.12+16.8% | -22.98+8.2% | -25.02 |
| KEY METRICS | ||||||||
| OPM % | -54.78%+45.21pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -44.74%+55.26pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.10+65.5% | -0.29-16.0% | -0.25+10.7% | -0.28+6.7% | -0.30+3.2% | -0.31+31.1% | -0.45+23.7% | -0.59 |
Corporate Events
Board MeetingFHTX
202624Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify th…
SEC Filing ↗